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Abnormal Arm Venograms identified  during PICC insertion in 
Chidren  (n=100) 
GROUP A - CVS/O with connection to SVC  (n=53) 
GROUP A: Post-Venogram Outcomes 
- success rate of PICC insertion 98% 
- Doppler US for new symptoms in 23% 
- Dx new thrombosis in 8% 
- median days of anticoagulation therapy  
 26.5 (4-1850)  
GROUP B: Post-Venogram Outcomes 
- success rate of PICC insertion 32% 
- Doppler US for new symptoms in 57% 
- Dx new thrombosis in 36% 
- median days of anticoagulation therapy 83 (2-1010) 
GROUP B - CVS/O without connection to SVC (n=47) 
GROUP B: History pre-venogram: 
- mean caliber of largest prior CVAD 4.5Fr 
- mean # of lumens 1.7 
- polyurethane as a prior CVAD 70% 
- malpositioning of prior CVAD 30% 
GROUP A: History pre-venogram: 
- mean caliber of largest prior CVAD 3.6Fr 
- mean # of lumens 1.3 
- polyurethane as a prior CVAD 25% 
- malpositioning of prior CVAD 13% A
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 V
en
og
ra
m
 
Statistical  
Differences 
Group A v. B 
 
p<0.001 
P=0.003 
P=0.002 
P=0.011 
 
Statistical  
Differences 
Group A v. B 
 
P<0.001 
p<0.001 
P<0.001 
P=0.044 
Time Line 
[CVS/O: central venous stenosis/obstruction;    CVAD: central venous access device;      NS: not significant] 
NS 
Graphical Abstract
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ABSTRACT 
Purpose: 
To explore the hypothesis that central venous stenosis/obstruction (CVS/O) in children are 
influenced by prior central venous access devices (CVADs) and associated with future risk 
for thromboses. 
Material and Methods: 
A convenience sample of 100 patients with abnormal venography (stenosis, collaterals, 
occlusions) documented during Peripherally Inserted Central Catheter (PICC) placements 
were identified from consecutive PICC placements (Jan 2008-Nov 2012). The patients (41M, 
59F, median age 2.7 years, median weight 11kg) were categorized based on venographic 
presence (Group A, n=53) or absence (Group B, n=47) of visible connection to the superior 
vena cava. Each patients’ CVAD history, pre- and post-venography, was analyzed (until 
October 2016).  
Results: 
Pre-venogram, Group B were associated with a higher number of prior CVADs, larger 
diameter devices, greater incidence of malposition and more use of polyurethane catheters 
than Group A (p<0.001). An ipsilateral PICC was successfully placed in 98% Group A, 
compared to 32% Group B (p<0.001). Post-venogram, significantly more Doppler 
ultrasounds (DUS) were performed, and thromboses diagnosed in Group B (57% and 36%) 
compared to Group A (21% and 8%) (p<0.003; p=0.001) respectively. 
Conclusion: 
Previous catheter characteristics influenced the severity of venographic changes of CVS/O 
(Group B). Group B was associated with more subsequent symptomatic thromboses.  This 
information may assist parents and referring physicians anticipate potential adverse sequelae 
from CVS/O on the child’s venous health. 
*Clean Revised Manuscript - No Author Information
Click here to view linked References
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INTRODUCTION: 
 
 Central vein stenosis or occlusion (CVS/O), a complication of central venous access 
devices (CVADs), may compromise future venous access, and result in venous stasis[1] [2] 
[3] [4]. CVS/O may occur from damage during CVAD insertion and from indwelling CVADs 
associated with turbulent flow, repetitive trauma, intimal hyperplasia, endothelial denudation 
and adherent thrombi [5] [6] [7].  CVS/O may be asymptomatic or symptomatic (e.g. edema 
of the ipsilateral extremity or the neck), and associated with thrombosis. The most prevalent 
risk factor for venous thromboembolism in children is a CVAD (80%) [4] [8].  
Venography during CVAD placement is not routine.  In children, stenosis, occlusions, 
and venous collaterals are frequently observed on venograms performed during difficult 
peripherally inserted central venous catheter (PICC) placements [2]. It is unclear what prior 
vascular access events lead to the development of CVS/O, e.g. types of CVADs, infections, 
or thromboses. It is also unclear what the clinical implications are for the child’s future vessel 
health when CVS/O are found (e.g. future risk of thrombosis, post-thrombotic syndrome, loss 
of central venous access) [9] [10] [11]. 
 The purpose of this study was to analyze the preceding vascular access events (pre-
venogram) and subsequent clinical impact (post-venogram) of CVS/O diagnosed in children. 
The hypothesis was that central venous stenosis/obstruction (CVS/O) in children is 
influenced by prior central venous access devices (CVADs), and associated with future risk 
for thromboses. 
 
MATERIAL AND METHODS 
 
Study Design:  
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 This retrospective cohort study was conducted in a tertiary care-level pediatric 
teaching hospital. Institutional Research Ethics Board approval was obtained. The study 
cohort was identified from radiology reports on consecutive patients who had an abnormal 
contrast venogram during an image-guided (ultrasound, fluoroscopy) upper extremity PICC 
insertion in interventional radiology (IR), regardless of diagnosis, indication or number of 
prior CVADs (Figure 1). The convenience target sample size was 100 abnormal venograms. 
Inclusion criteria were patients undergoing an upper extremity PICC placement with 
abnormal venography showing deep venous stenosis or occlusion of the subclavian, 
brachiocephalic, or the superior vena cava (SVC), and/or opacification of venous collaterals. 
Patients were excluded if no venogram was performed, venogram was normal, images not 
stored or image quality too poor to assess vessel patency. Only abnormalities of the central 
venous system were included. Abnormalities of the superficial and deep veins of the arm 
(brachial, cephalic, basilic veins) were excluded (Fig. 1).  
 
The search period started in January 2008, to ensure a sufficient sample size and to allow 
adequate follow-up for all patients. The target (n=100) was reached in November 2012, 
providing minimum follow-up of 4 years (study terminated 2016). The 100 patients were 
categorized into two groups by authors XX (radiologist 9 years experience) and YY, (medical 
student, co-author), with a review of 10 cases for consensus / audit purposes, by radiologist 
(ZZ, 24 years experience). Groupings were based on extent of the abnormalities seen on 
venography and divided into Group A and Group B, with the venographic changes more 
extensive in Group B: 
Group A: Abnormal appearance (stenosis, wall irregularities or occlusion) of the 
central veins (subclavian, brachiocephalic or SVC), and visible venous collaterals, 
with an opacified connection to the SVC - through the native vein or a collateral (Fig. 
2). 
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 4 
Group B: Abnormal appearance (stenosis, wall irregularities or occlusion) of the 
central veins (subclavian, brachiocephalic or SVC), and visible collaterals, but 
without any opacified connection to the SVC (Fig. 3). 
 
Results were organized and analyzed in two-time frames: pre-venogram and post-
venogram. Each patient’s CVAD history, pre- and post-venography, was examined, with 
follow up (October 2016). A subanalysis was performed to examine the effect of age (≤ 6 and 
> 6 months). 
 
Data Collection: 
Data was collected from the Electronic Patient Charts, Vascular Access Database, the 
IR Database (Esh-IGT, www.esh.ca; Ontario, Canada), a Hematology Departmental Database 
(Thrombosis), and PACS (GE, Milwaukee, USA). All feasible cross-referencing and 
confirmation techniques were employed between databases to ensure accuracy of the data.  
To determine potential risk factors for developing CVS/O, the following was 
recorded:  
Pre-venogram: (i) patient demographics at the time of the venogram, (ii) number, type, size 
and dwell times of all prior CVADs in the patient’s history (including PICCs, central venous 
catheters, hemodialysis catheters, ports), number of venous Doppler ultrasounds (DUS) 
performed; number of thromboses diagnosed, and anticoagulation, (iii) most recent catheter 
in-situ prior to the venogram (called antecedent device) including the catheter material 
(silicone or polyurethane), cuffed or uncuffed, side employed (left or right), vein used 
(basilic, brachial, subclavian, cephalic, internal jugular), indication for catheter 
(chemotherapy, antibiotics, total parenteral nutrition (TPN), medication, and/or fluids), and 
complications (thromboses, infection, malposition).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 5 
 
Post-venogram: success or failure of PICC placement during procedure with venogram, 
thromboses post-venogram (number of DUS examinations performed and thromboses 
diagnosed), anticoagulation and clinical sequelae from thrombosis (e.g. superior vena cava 
syndrome (SVCSyn), post thrombotic syndrome (PTS), chylothorax (CThx)). Prior cardiac 
surgery was recorded as a risk factor for developing above sequelae. 
 
Definitions and Practice:  
 Central veins included SVC, brachiocephalic and subclavian vein. The deep veins 
included SVC, brachiocephalic, internal jugular, subclavian, and axillary. The superficial 
veins included the cephalic, basilic, and external jugular veins. Thromboses were diagnosed 
on venous DUS pre- and post-venogram and defined using recognized sonographic criteria 
[12] .A sonographically confirmed thrombus (occlusive or non-occlusive) was counted as one 
event; subsequent thrombus found in a different vein was counted as a second event. Venous 
DUS assessment was performed on site: a) in clinically indicated symptomatic children (e.g. 
extremity swelling, pain, leaking at the CVAD site, or catheter malfunction suggestive of 
venous occlusion); or b) for follow up of a known thrombosis. Routine DUS thrombosis 
surveillance screening was not performed. Catheter related blood stream infections (CRBSI) 
were laboratory proven. Catheter malpositions were based on radiographs. 
Anticoagulation was defined as prophylactic (i.e. half of the treatment dose) or 
therapeutic (i.e. full treatment dose) based on recognized criteria using variety of medications 
across all age groups (footnote Table 2) [13]. Prophylactic anticoagulation was only 
administered after CVAD insertion in patients with a history of a previous thrombosis and 
continued until removal of the CVAD. Therapeutic anticoagulation was administered 
following a documented deep venous thrombus usually for three months, or longer if 
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persistence of the thrombotic risk factor was demonstrated, as per international guidelines 
[13]. PTS was defined as per the modified Villalta score (Mild Moderate, Severe), a 
commonly used pediatric instrument for PTS detection [14], in the Thrombosis Clini[15]. 
Mild PTS corresponds to greater than 1 cm circumference differences with the contralateral 
arm and/or increased ipsilateral venous collaterals [14] [15]. 
 
 
Venography 
 A venogram, including shoulder and upper chest area, was performed during PICC 
placement at the discretion of the interventionalist, if difficulty was encountered advancing a 
guide wire or catheter centrally into the brachiocephalic vein and/or SVC. Contrast was hand-
injected from the initial access site (basilic, cephalic, brachial, axillary vein), through a 
dilator, or through the non-advanced PICC.  
 
Patient Population 
 
 Of 3,862 PICCs placed in IR (2008-2012), 100 abnormal venograms were identified 
(Figure1). There were 41 boys and 59 girls. The mean patient age was 2.7 years and mean 
weight 11 kg (Table 1); The CVS/Os  involved the right upper extremity in 94, and the left in 
six. Fifty-three venograms were categorized into Group A and 47 venograms into Group B; 
49 patients were ≤ 6months, and 51 >6months. There was no statistical difference in age, 
weight or gender between Group A and B (p>0.05). 
 
 Statistical Analysis: 
SPSS version 23.0 for Windows (SPSS Inc., Chicago, IL) was used. Frequency 
distributions and cross-tabulations of variables of interest were obtained. The Shapiro-Wilk 
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 7 
test was used to assess normal distribution. Results were expressed as mean ± SD or median 
where appropriate. Student’s t-test or Mann–Whitney U test was used for group comparisons 
for continuous variables. Chi-square or Fisher exact test was used to compare categorical 
variables. Differences were considered significant at p<0.05 (two-tailed); p>0.05 were not 
significant, NS.  
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RESULTS 
 
PRE-VENOGRAM 
History of all CVADs Pre-venogram 
The 100 patient cohort had received 437 prior CVADs, median of 1.73 CVADs per 
patient (range 1 - 7). The median cumulative dwell time of prior CVADs was 112 days (range 
1-1429 days). The difference between Group A and B for number of CVADs and dwell time 
was not significant (Table 1). The median size of CVADs pre-venogram was 4.1 French 
(range 1.9 - 10) and the number of lumens 1.47 (range 1 - 2). There was a significant 
difference between Group A and B in the patient’s largest prior CVAD (p<0.001) and the 
number of lumens (p<0.001) (Table 1). Group B was almost 3 times more likely to have had 
an ipsilateral polyurethane catheter compared to Group A (RR: 2.86, CI: 1.72 – 4.76, 
p<0.001). The size of prior CVADs, number of lumens and dwell times were significantly 
greater in those > 6 months than ≤ 6months (p=0.026, p=0.005, p=0.027 respectively).  
The Antecedent Device Pre-venogram 
The antecedent catheter pre-venogram showed no significant difference between 
Group A and Group B in the following: use of cuffed or noncuffed catheters (p=0.13), vein 
accessed (p=0.11), indication for device: TPN (p=0.21), antibiotics (p=0.85), medication 
(p=0.81), nor for device infection (p=0.42) or blockage (p=0.75).  In Group B the antecedent 
catheter was more commonly of polyurethane material (p<0.001) and malpositioned (p=0.04) 
than Group A (Table 1). Both infection and malposition rates were higher than the 
institutional average for the relevant years (2008 – 2012; 6% and 8% respectively).  
Diagnosis of Thromboses Pre-venogram 
 Seventy five DUS on the ipsilateral arm/central veins had been performed to evaluate 
new symptoms in 46/100 patients with 37 new thromboses diagnosed in 29/46 patients (Table 
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2). More DUS were performed and thromboses diagnosed in Group B than Group A, but 
differences were NS (p=0.073 and 0.137 respectively). 
Anticoagulation Pre-venogram 
Six patients had been on prophylactic anticoagulation (2 in Group A, 4 in Group B), 
and 26 patients on therapeutic anticoagulation (12 in Group A, 14 in Group B) (Table 2). The 
median duration of prophylactic treatment in Group A was shorter than Group B, and median 
duration of therapeutic treatment longer in Group A than Group B, but the differences NS 
(Table 2).  
 
POST-VENOGRAM 
An ipsilateral PICC was successfully placed in 52/53 (98%) patients in Group A, 
compared to 15/47 (32%) in Group B (p<0.001).  
Diagnoses of Thromboses Post-venogram 
Seventy-one ipsilateral DUS were performed in 38/100 patients due to the onset of 
new symptoms, and 33 new thrombi diagnosed in 22/38 patients (See details in Table 2).  
Group B were significantly more likely to require a DUS (p=0.003; ≤6months p=001; 
>6months p=0.007) and have a new thrombosis (p=0.002; ≤6months p=0.045; > 6months 
p=0.001) than Group A. Subset analysis of the 15 patients in Group B with a successful PICC 
showed 13 (89%) had ipsilateral DUS performed for new symptoms and new thromboses 
diagnosed in 8/13 (62%) patients (Fig. 4). The differences in ipsilateral thromboses between 
Group A and B with a successful PICC were highly significant (chi-square = 16.49; 
p<0.0001). 
 
Anticoagulation Post-venogram 
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Post-venogram 6/47 patients received prophylactic anticoagulation (4 in Group A; 2 
Group B), and 29/47 patients required therapeutic anticoagulation (12 Group A; 17 Group B). 
The median duration of therapeutic anticoagulation was significantly longer in Group B 
(p=0.011), the differences in prophylaxis duration was NS (p=0.368). 
 
Clinical Sequelae Post-venogram   
The Hematology/Thrombosis Team monitored 38 patients for 51 new thromboses, 
including 12/38 monitored both pre and post venogram (1 was followed up elsewhere). Six of 
the 38 patients (15%) patients were diagnosed with PTS (2 Group A; 4  Group B), 8/38 
(21%) with CThx (1 Group A; 7 Group B), and 2/38 (5%) with SVCSy (1 Group A and 1 
Group B). An underlying cardiac diagnosis was noted in 20/38 patients. PTS and CThx 
occurred more commonly in those with underlying cardiac disease (4/20 (20%) and 7/20 
(35%)) respectively, compared to those without cardiac pathology (2/18 (11%) and 1/18 
(5.6%)) respectively (difference marginally significant p=0.056). SVCSy was similarly 
distributed between patients with and without an underlying cardiac disease (1/20 (5%), 1/18 
(5.6%)). 
 
 
DISCUSSION 
 
 Awareness of vessel health in children and preserving their venous access sites is a 
key responsibility of the pediatric interventional radiologist, especially in children with 
complex co-morbidities who face long-term or even lifelong vascular access needs [9-11]. 
The pediatric interventionalist may achieve this by simple measures e.g. ensuring a good 
indication for every inserted CVAD, reviewing prior imaging, placing the smallest size and 
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fewest lumens to serve the child’s needs, placing the CVAD tip centrally, and changing 
access sites only when necessary.  
CVS/O is clinically important impacting the blood return to the heart. In severe cases, 
the entire upper venous system is compromised. This study explored a select group of 
children diagnosed with CVS/O, to evaluate factors associated with the development of 
CVS/O, as well as the sequelae of CVS/O. The cohort was associated with a higher incidence 
of previous infection and malposition than the institutional average. Patients in Group B were 
associated with larger diameter, more lumens, malpositions and use of polyurethane catheters 
in their prior CVADs than those in Group A. Successful PICC placement was significantly 
less frequent in Group B, with greater likelihood of subsequent symptoms (need for DUS, 
thromboses  diagnosis and therapeutic anticoagulation).  
The success rate for PICC placement in the ipsilateral arm with CVS/O (68% overall, 
Group A and B combined) was lower than in an adult cohort by Park et al (86%) [16]. A 
lower success rate was not unexpected as it included young children (mean age 2.7 years, 
mean weight 11 kg) compared to adults. Stenosis in preexisting small veins would more 
likely prevent successful passage of a new PICC. Impact of these stenoses was seen in the 
numbers of patients who became symptomatic and required a DUS post PICC, indirectly 
indicating the critical nature of the stenosis with development of stasis/congestion symptoms 
in the presence of a new space occupying PICC. 
The incidence of CVS/O after PICC or Port-a-cath insertion has been reported to be 
approximately 7% [10]. In the same period of this study (2008-2012), 3,862 PICCs were 
placed in this institution. Identification of only 100 abnormal venograms is therefore low 
(~2.6%). Over half the cohort (54%) had never undergone a prior DUS, i.e. they were 
asymptomatic, and CVS/O only became apparent during the difficult PICC insertion, 
suggesting CVS/O are frequently silent. Conversely not all symptomatic children were found 
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to have associated thromboses on DUS. The cohort did not account for others who may have 
had CVS/O or thrombosis, but who did not undergo a subsequent PICC or venography, and 
remained undetected. The incidence of PICC associated peripheral thromboses detected by 
screening ultrasound in adults is much higher (72%) [17]. The 100 children studied therefore 
represent the tip of an iceberg. The division into two groups based on the extent of 
venographic abnormalities, show clinically relevant differences in severity of CVS/O 
between both groups (requirement for US, success of ipsilateral PICCs, diagnoses of 
thromboses and clinical sequelae), with Group B more symptomatic than A, pre- and post-
venogram.  
 
The mechanism for forming CVS/O is not always known. Potential contributors are 
vessel wall damage at the time of insertion, indwelling catheters causing continuous 
endothelial damage, intimal hyperplasia, turbulent flow and thromboses [5] [18]. The 
preponderance on the right side reflected the institutional practice of using the right arm as 
first option for CVAD placement. The significant difference in catheter size and number of 
lumens between Group A and B potentially contributed to CVS/O. The relative size of vein 
to catheter is important, as the vein diameter is small in infants. Although no measurement of 
the diameters of the veins were taken, the vein sizes were likely similar as there was no 
significant difference in the ages and weights of patients in Group A or B. The mean age (2.7 
years) and weight (11kg) of the cohort are younger and smaller than the institutional average 
of patients undergoing a PICC (4.5 years; 18kg) suggesting that CVS/O might be more 
common in smaller children. Whether ≤6months and > 6 months, Group B required more 
DUS and were diagnosed with more thromboses post venogram that Group A. However 
differences in variables such as dwell times, largest diameter and number of lumens of prior 
CVADs were more significant in those >6months than ≤ 6months in Group B than A. 
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Endothelial damage during catheter insertion may contribute to CVS/O. Inserting a 
double lumen PICC over a single wire results in an eccentric wire, and the vessel wall prone 
to damage from the blunt tip of the catheter. In this cohort, 43% double lumen CVADs 
(188/437) had been placed, whereas the institutional average in the same timeframe was 21% 
(819/3862). Vein injury also may occur from the catheter  lying in contact with the vessel 
wall. Arm movement, breathing, and cardiac cycles causes catheter movement with friction 
on the endothelium [19]. Even short-term catheters can be associated with focal intimal 
injury and thrombus formation [18]. Significantly more polyurethane catheters were used in 
Group B compared to Group A, suggesting catheter material is important [20]. Although 
polyurethane softens at body temperature, polyurethane is a stiffer material than silicone. 
Surface irregularities on polyurethane devices make them more susceptible to thrombus 
adhesion [21, 22]. 
 
The present study has several limitations. A convenience sample was a chosen as a 
representative subgroup, but actual incidences may vary if a large prospective study was 
undertaken. The search terms may have overlooked or missed some cases.  This study was 
not designed to determine causation for CVS/O. Differently designed prospective studies 
would be required to determine causality and validate findings of this study. A strength of the 
paper was the creation of a select cohort of patients with documented abnormal venography. 
Division into two groups was based on venographic patterns, which is prone to assignment 
error and inherent variability in venographic technique. Venographic image quality varied 
depending on the contrast volume injected which was usually small, and use of fluoroscopy 
or DSA. More precise characterization of the venographic abnormalities seen on venogram 
(e.g. assigning percentage stenosis, enumerating collaterals) would be inaccurate, due to such 
technical inconsistencies. Classification was based on an opacified venous connection to the 
SVC regardless whether it was a collateral or native vein. Park et al classified CVS/O and 
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collaterals into three groups depending on distribution and degree of venous collaterals 
identified on venogram [16]. The rationale behind the classification used here was that 
symptoms (congestion, swelling, pain) are less likely if there is any route for adequate venous 
drainage of the limb (i.e. connection to SVC, Group A). The duration of CVS/O changes 
(acute or long standing) could not be determined. Prior catheter insertions were assumed not 
to be difficult (as no venogram had been performed). No measurement of vein sizes was 
available, so correlation with PICC French size was not done. No clinical comparisons were 
made between both groups in Hematology/Thrombosis follow-up clinics. Prophylactic 
anticoagulation may have been under-reported. 
 
The findings indicate previous catheter characteristics (material, size, number of 
lumens, malposition) influence the severity of CVS/O. Detection of CVS/O on venography is 
associated with subsequent symptoms, with or without thromboses requiring anticoagulation. 
Many CVS/Os remain undiagnosed. It is debatable if a PICC should be placed ipsilaterally to 
CVS/O if there is no visible venous SVC connection, as thromboses are significantly more 
likely to occur. Adverse outcomes of PTS, SVCSy and CThx are more likely to occur in 
those with concomitant cardiac pathology (marginally significant). It behooves the 
interventionalist to review available images while planning a PICC. This study provides 
important information for the pediatric interventionalist to share with parents and referring 
physicians, to anticipate potential adverse sequelae on the child’s future venous health.  
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FIGURES 
 
 
Figure 1: 
 
Flow Chart of the patient cohort. 
 
 
 
Figure 2: 
 
 
Example of venograms categorized as narrowing by the interventionalists (Group A). (a) 7-
year-old boy with two previous PICCs in the right arm. Vascular access was performed 
through the basilic vein. The venogram shows an abnormal appearance of the 
axillary/subclavian vein (arrow) but with a clear connection to the SVC (star). The PICC was 
placed without further issues on the ipsilateral arm. (b) 5-year-old girl with one previous 
PICC in the right arm. Oblique view of DSA (Digital Subtraction Angiography) from a 
brachial access shows two large draining veins however there is still a connection to the 
SVC. PICC was placed through the lower branch. 0.014” wire perforated this branch without 
further complications. 
 
 
Figure 3: 
Examples of venograms categorized as occlusions by the interventionalists (Group B). (a) 2-
year-old boy with two previous PICCs and a temporary right jugular catheter. Vascular 
access was performed through the brachial vein. The venogram shows complete occlusion of 
the axillary/subclavian vein. Note: sternal wire from prior cardiac surgery. After several 
attempts to advance the wire into the SVC, the right arm was abandoned and the PICC placed 
in the left arm. (b) 3-year-old girl with one previous right arm PICC. Access was made 
through the basilic vein, venogram showed complete occlusion of the subclavian vein with 
large collaterals descending the right lateral chest wall. 
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Figure 4: 
Venogram from a right arm vein in an 8-year-old female with prior PICC placed in the right 
arm. The native axillary vein is opacified but with complete occlusion of the subclavian vein 
(star). Opacification of the SVC (arrow) through collaterals is seen. Ultimately, a PICC was 
successfully placed through the occluded subclavian vein. Patient had an ultrasound due to 
severe swelling of the right arm at Day 2 and at Day 5 post-PICC insertion, a thrombus was 
seen in the right axillary vein.  
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TABLES 
 
 
Table 1. Clinical and Line Characteristics Pre-venogram 
 
All Lines Group A (n=53) Group B (n=47) p Value 
Age in years: Mean (median, range) 2.9  (0.5; 0,04 – 17.3) 2.6 (0.5; 0,05 – 17.9) 0.73 
Weight in kg: Mean (median, range) 11.9 (4.45; 0.68 – 69.3) 10.3 (4.75; 0-66) 0.71 
Gender Male / Female 21 / 32 20 / 27 0.97 
Mean # of devices before venogram 1.8 1.7 0.82 
Mean French size of largest line 
before venogram 3.6 4.5 p<0.001 
Mean # of lumens of lines placed 
before venogram 1.3 1.7 p<0.001 
Mean dwell time, days 111.3 112.6 0.113 
Details of Antecedent Line Pre-venogram 
Material Silicone / Polyurethane 40 /13 14/33 p<0.001 
Vein used for CVAD prior to 
venogram IJV/SV/ DV* 7 / 34 / 12 8 / 18 / 21 0.11 
Line cuffed 43 32 0.13 
Usage of line prior to venogram 
x TPN 
x Antibiotics 
x Medication 
 
 
21 
19 
13 
 
 
13 
16 
18 
 
 
0.21 
0.85 
0.81 
Infection 11  13 0.42 
Malposition**  7 14 0.04 
Blockage 6  4 0.75 
 
Legends:  
*IJV=internal jugular vein, SV=superficial vein, DV=deep vein 
** Malposition: Common malpositions include: a) central tip flipping into the contralateral brachiocephalic vein 
or jugular vein; b) tip ascending high with growth, into the SVC or inominate, c) descending low into the right 
atrium,   
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Table 2. Comparison of Frequency of Ultrasounds, Thromboses, and Anticoagulation 
Regimens Pre- and Post-venogram 
: 
VARIABLE GROUP A 
(n=53)  
Group B  
(n=47) 
PRE-
VENOGRAM 
POST-
VENOGRAM 
p-Value comparing  
Pre- to Post- 
Venogram 
# DUS for new 
symptoms 
[# of patients] 
Group A  33  [22] 21 [11] 0.202 
Group B  42 [24] 50 [27] 0.243 
p-Value comparing 
Group A to Group B 
P=0.073 P=0.003  
 
DUS binomial* 
(Yes/No) 
Group A  22 (42%) 11 (23%) 0.002 
Group B  24 (51%) 27 (57%) 0.250 
p-Value comparing 
Group A to Group B 
P=0.422 P<0.0001  
 
# New 
thromboses 
diagnosed  
[# of patients] 
Group A  14 [12] 7 [4] 0.002 
Group B  23 [17] 26 [17] 0.250 
p-Value comparing 
Group A to Group B 
P=0.137 P=0.022  
 
Thrombosis 
binomial* 
(Yes/No) 
Group A  12 (23%) 4 (8%) 0.202 
Group B  17 (36%) 17 (36%) 0.389 
p-Value comparing 
Group A to Group B 
P=0.185 P=0.001  
     
Median (range) # 
of days of 
ProphylacticP 
Anticoagulation  
[# of patients ] 
Group A  16 (8-24) [2] 118 (1-278) [4]  0.225 
Group B  32 (3-65) [4] 123(19-228) [2] 0.715 
p-Value comparing 
Group A to Group B 
P=0.394 P=0.368  
 
Median (range) # 
of days of 
Therapeutic T 
Anticoagulation  
[# of patients] 
Group A  75 (2-322) [12] 26.5 (4-1850 [12] 0.460 
Group B  20.5 (3-538) [14] 83 (2-1010) [17] 0.022 
p-Value comparing 
Group A to Group B 
P=0.963 P=0.011  
 
# number 
DUS: Doppler ultrasound 
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Binomial (Yes or NO) = all ultrasound / thromboses are counted as one per patient, 
irrespective of number per patient 
 
P Prophylactic anticoagulation agents - heparin or enoxaparin used.  
 
T Therapeutic anticoagulation agents – heparin ,enoxaparin, tinzaparin or warfarin.Rarely 
argatroban,  
 
P, T    Anticoagulants included agents used to inhibit thrombin formation such as heparinoids 
[e.g., unfractionated heparin [UFH/heparin], low molecular weight heparin 
[LMWH/enoxaparin/tinzaparin], oral vitamin K antagonist [warfarin], and direct thrombin 
inhibitors [argatroban]). In terms of dosing, anticoagulants were used in either therapeutic 
dose (i.e., full dose) or in prophylactic dose (i.e, corresponding to 50% of full dose) and 
titrated per kilogram body weight. No difference in agents used in children ≤ 6months or > 6 
months  except Tinzaparin used in two children aged 4 and 7.5 years. Warfarin was used 
exclusively in children with cardiac surgical conduits/baffles to maintain patency with a 
mean age of 3.6 years (versus 1.5 to 1.7 for heparin and enoxaparin, respectively). 
Antiplatelet agents (aspirin) were used in seven patients post cardiac surgery or liver 
transplantation to maintain patency of vessels, not for clot therapy. 
 
 
 
 
 
